SCHEMBL7523653

SCHEMBL7523653

CN(C(=O)OC(C)(C)C)c1ncc(C(=O)NC2CC3CCC2CC3)s1

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BRS3 P32247 4/20 0.36
CYP3A4 P08684 1/20 0.34
HSD17B10 Q99714 2/20 0.34
ALDH1A1 P00352 2/20 0.32
HTT P42858 2/20 0.32
LMNA P02545 1/20 0.32
TAS1R3 Q7RTX0 1/20 0.32
TAS1R1 Q7RTX1 1/20 0.32
TAS1R2 Q8TE23 1/20 0.32
TMPRSS15 P98073 2/20 0.31
USP30 Q70CQ3 2/20 0.31
ABL1 P00519 1/20 0.31
CNR2 P34972 1/20 0.31
PANK3 Q9H999 1/20 0.31
KDM4E B2RXH2 1/20 0.30
HPGD P15428 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7202680 0.84 CHRNA7 (0.46)
SCHEMBL6501667 0.81 CHRNA7 (0.41) ABL1
SCHEMBL6496980 0.73 HCAR2 (0.44) CYP3A4HSD17B10ALDH1A1TMPRSS15USP30
SCHEMBL28474114 0.72 ALDH1A1 (0.41) ALDH1A1TMPRSS15USP30ABL1TSHR
SCHEMBL6496922 0.71 CDC7 (0.46) HSD17B10ALDH1A1TMPRSS15USP30HPGD
SCHEMBL7652150 0.68 CHRNA7 (0.51)
SCHEMBL12715430 0.67 PAX8 (0.41) ALDH1A1LMNAUSP30ABL1TSHR
SCHEMBL12744103 0.66 USP30 (0.39) ALDH1A1USP30ABL1TSHR
SCHEMBL11723390 0.65 HSD17B10 (0.45) CYP3A4HSD17B10ALDH1A1HTTLMNA
SCHEMBL12824358 0.65 ALDH1A1 (0.44) CYP3A4ALDH1A1USP30KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002015662-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO disclosed
WO-2002017358-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC ACETYLCHOLINE RECEPTOR ANTAGONISTS) PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO disclosed